newsroompost
  • youtube
  • facebook
  • twitter

Made in India vaccines to boost PM Modi’s vision of Aatmanirbhar Bharat: Amit Shah

COVID-19 vaccines of SII, Bharat Biotech approved for restricted use in emergency situation

New Delhi: The Drugs Controller General of India has approved both Serum Institute of India and Bharat Biotech’s COVID-19 vaccines for restricted emergency use in the country.

DCGI said that the interim data suggests that the vaccine (Cadila Healthcare’s vaccine) is safe and immunogenic with three doses when administered intradermally.

India closer to Covid-19 vaccine, Drug Controller hints for approval

Here is who said what: